home / stock / coll / coll articles

COLL Articles, Collegium Pharmaceutical Inc.

Stock Information
Company Name: Collegium Pharmaceutical Inc.
Stock Symbol: COLL
Market: NASDAQ
Website: collegiumpharma.com
Menu
COLL COLL Quote COLL Short COLL News COLL Articles COLL Message Board
Get COLL Alerts

News, Short Squeeze, Breakout and More Instantly...
Collegium to Participate in Jefferies Global Healthcare Conference | Benzinga

STOUGHTON, Mass., May 29, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutica...
Collegium Announces CEO Transition | Benzinga

– Joe Ciaffoni to Step Down as President and Chief Executive Officer – – Board Chairman Michael Heffernan to Serve as Interim President and ...

Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024 | Benzinga

STOUGHTON, Mass., Feb. 08, 2024 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutic...

Why Collegium Pharmaceutical Shares Are Gaining Today | Benzinga

Collegium Pharmaceutical, Inc. (NASDAQ: COLL) today announced FY24 financial guidance and provided a business update. COLL expects FY24 P...
TDCX Receives Preliminary Non-binding Proposal Letter, Joins Pure Storage, Dyne Therapeutics And Other Big Stocks Moving Higher On Wednesday | Benzinga

U.S. stocks traded lower, with the Nasdaq Composite falling around 150 points on Wednesday. Shares of TDCX Inc. (NYSE: TDCX) rose sharply during We...

Appeals Court Upholds PTAB's Finding of Invalidity of Purdue's 961 Patent | Benzinga

STOUGHTON, Mass., Nov. 27, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutica...

Collegium Announces $25 Million Accelerated Share Repurchase Program | Benzinga

STOUGHTON, Mass., Nov. 09, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutica...
Collegium to Participate in Upcoming Investor Conferences | Benzinga

STOUGHTON, Mass., Nov. 08, 2023 (GLOBE NEWSWIRE) -- Collegium Pharmaceutical, Inc. (NASDAQ:COLL), a leading, diversified specialty pharmaceutic...

Next 10